Kusajili – Clinical trials directory

Result of your search per specialist: Miss Ailsa Weatherall

Woman and Man Max 99 years
Merck Sharp & Dohme Ltd. (MSD) (UK) Update Il y a 5 ans

A phase II baseline versus treatment study to determine the efficacy of raltegravir (ISENTRESS) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI Not provided at time of registration

Country None
organs None
Specialty None

Closed trial

More information